Sensyne Health: Putting Sensyne Health at the Future of Medicine
Brands2Life was tasked with establishing an innovative, digital and analytical communications programme in the UK to raise the profile of Sensyne Health amongst its core audience groups, as a trusted guardian of patient data and an innovator in AI and healthcare.
With limited brand knowledge amongst the pharma and health audience, Brands2Life developed a ground up UK thought leadership programme, starting with trade media to establish Sensyne Health as the leading clinical AI company, accelerating the drug development and discovery process. Through regular thought leadership content, blog articles, news announcements and senior exec profiling, we ensure Sensyne Health is front of mind for any journalist writing about health technology. We have recently added a dedicated speaker bureau programme to our day-to-day activity, where we identify, pitch and manage top-tier editorial speaking platforms for their senior leadership team.
Alongside earned media, we have also led several paid social campaigns, including one as part of the launch of their COVID-19 symptom tracking app, CVm-Health. Finally, we have managed display ad campaigns in health and pharma trade titles to support the launch of the app as well as boost brand awareness.
In less than a year, we have secured +70 pieces of coverage including news announcements, bylines and interview Q&As. This includes coverage in titles such as Pharmaphorum, Journal of mHealth, Silicon UK, Oxford Mail, Med-tech Innovation, Digital Health and Building Better Healthcare.